[1] |
Rass V, Helbok R. Early brain injury after poor-grade subarachnoid hemorrhage[J]. Curr Neurol Neurosci Rep, 2019, 19(10): 78.
|
[2] |
肖志朋,崔雨迪,潘耀华,等.血管内栓塞颅内微小动脉瘤的临床疗效分析:单中心前瞻性研究[J].中国脑血管病杂志, 2021, 18(1): 25-29.
|
[3] |
崔冬强,冯铭,束旭俊,等.增强现实技术辅助神经内镜与小骨窗开颅血肿清除术治疗高血压脑出血疗效分析[J].中国现代神经疾病杂志, 2019, 19(9): 654-660.
|
[4] |
Van Ornam J, Pruitt P, Borczuk P. Is repeat head CT necessary in patients with mild traumatic intracranial hemorrhage[J]. Am J Emerg Med, 2019, 37(9): 1694-1698.
|
[5] |
唐海涛,鞠盛国,陈刚,等.神经内窥镜与穿刺引流术治疗基底节区自发性高血压脑出血的临床比较[J].中国实用医药, 2018, 13(25): 16-18.
|
[6] |
侯晓鹏,范益民,刘晓东,等.经侧裂-岛叶入路早期显微手术治疗基底节区脑出血体会[J].中国医学创新, 2014, 11(14): 131-133.
|
[7] |
中国急诊急救神经内镜治疗高血压性脑出血协作组,中国医药教育协会神经内镜与微创医学专业委员会,中华医学会神经外科分会. 2020神经内镜下高血压性脑出血手术治疗中国专家共识[J].中华医学杂志, 2020, 100(33): 2579-2585.
|
[8] |
杜涛明. MSCT在预测高血压脑出血早期血肿扩大中的临床价值[J].现代临床医学, 2019, 45(5): 352-353.
|
[9] |
邹滔滔.内镜辅助下高血压脑出血微创手术治疗的临床疗效探讨[J].基层医学论坛, 2019, 23(28): 4061-4062.
|
[10] |
刘志学,张晓燕,马丽红.基底节高压性脑出血MSCT分级与其预后的相关性分析[J].中国CT和MRI杂志, 2019, 17(9): 14-16, 79.
|
[11] |
李振勇,雷昆,胡波,等.不同时间手术治疗高血压脑出血的临床效果比较[J].临床合理用药杂志, 2019, 14(26): 108-112.
|
[12] |
Vales-Montero M, García-Pastor A, Iglesias-Mohedano AM, et al. Cerebral amyloid angiopathy-related transient focal neurological episodes: a transient ischemic attack mimic with an increased risk of intracranial hemorrhage[J]. J Neurol Sci, 2019, 406: 116452.
|
[13] |
Hernández-Durán S, Mielke D, Rohde V, et al. Does nimodipine interruption due to high catecholamine doses lead to a greater incidence of delayed cerebral ischemia in the setting of aneurysmal subarachnoid hemorrhage?[J]. World Neurosurg, 2019, 132: e834-e840.
|
[14] |
Kaiser J, Schebesch KM, Brawanski A, et al. Long-term follow-up of cerebral amyloid angiopathy-associated intracranial hemorrhage reveals a high prevalence of atrial fibrillation[J]. J Stroke Cerebrovasc Dis, 2019, 28(11): 104342.
|
[15] |
侯国勇.早期强化降压联合尼莫地平治疗高血压脑出血临床疗效观察[J].医药论坛杂志, 2019, 40(01): 36-38.
|
[16] |
季占胜.超早期强化降压治疗对脑出血血肿扩大、血浆MMP-9及神经功能的影响[J].中外医疗, 2018, 37(2): 60-62.
|